A growing body of evidence has linked the anti-nausea medication Zofran (Ondansetron) and Zuplenz to an increased risk of congenital heart defects and other birth defects. At least one study has suggested that expectant mothers who were treated with the drug during their pregnancy were twice as likely to have a baby with serious heart defects compared to those who hadn’t used the medication.
The nationwide law firm of Bernstein Liebhard LLP is currently reviewing legal claims involving alleged Zofran heart defects. You may have a valid claim for compensation if you took Zofran while pregnant and gave birth to a child with:
Babies with serious heart birth defects can require years of special medical care, and they may experience lasting health consequences throughout their lives. By filing a Zofran lawsuit now, you may be able to obtain compensation from GlaxoSmithKline for all of the injury-related damages caused by your child’s birth defect, including past and future medical bills, lost wages, and pain and suffering. If you would like to learn more about the legal options available to you, please call our office today for a free review of your case.
Zofran is approved to treat nausea and vomiting in patients undergoing certain types of radiation and chemotherapy treatments. It is also indicated to alleviate post-operative nausea or vomiting. However, the medication has never been approved to treat pregnant women with severe morning sickness, and its safety in pregnancy has never been well-evaluated. Still, Zofran has routinely been prescribed to women who suffer from extreme nausea and vomiting related to morning sickness.
A number of studies have found evidence that taking Zofran in pregnancy may increase the chances that a baby will be born with a serious heart abnormality. For example, in 2013, a study looking at pregnancy data from a Danish health registry data found that Zofran was associated with a 30% increased risk of birth defects overall, and a two-fold increased risk of heart abnormalities. In December 2014, a study published in Reproductive Toxicology suggested that Zofran could double the risk that a child will be born with septal heart defects, including atrial septal defects and ventricular septal defects.
According to a 2014 report from The Toronto Star, heart problems reported in children expose to Zofran before birth include:
If you’re baby was born with a Zofran heart defect, you can hold GlaxoSmithKline accountable for the harm caused to your child. To learn more about the legal process for filing a Zofran lawsuit, please contact Bernstein Liebhard LLP today by calling .